AI and genomics drive global NGS market to $29.5b by 2030

APAC is expected to be the fastest-growing market.

The global next-generation sequencing (NGS) market is projected to grow from $14.94b in 2025 to $29.53b by 2030, registering a CAGR of 14.6%, according to a new report by MarketsandMarkets.

Market growth is being fuelled by increased government funding for sequencing projects, rising applications of NGS in chronic disorders, and expanding use in clinical diagnostics.

Advances in bioinformatics and data analytics are also playing a key role, enabling faster processing of sequencing data and extraction of actionable insights.

Meanwhile, declining sequencing costs are broadening accessibility for applications in personalised medicine, genome research, and large-scale population genomics initiatives.

The integration of AI and machine learning into sequencing workflows is further improving efficiency and accuracy, accelerating innovation in the field.

In terms of offerings, the products segment leads the market, supported by recurring revenue from consumables and high-priced instruments, while services remain the second-largest segment.

Sequencing by synthesis dominates platform technologies, followed by ion semiconductor sequencing. Sequencing services are the largest service type, with bioinformatics and data analysis services ranking second.

Diagnostics is the leading application, driven by routine clinical use and large-scale screening programs, and academic and research institutes are the largest end users, adopting advanced technologies such as single-cell sequencing and spatial transcriptomics.

The Asia-Pacific region is expected to be the fastest-growing market, fuelled by infrastructure development, population genomics initiatives, and collaborations between pharmaceutical and biotechnology companies.